Ritter Pharma Lactose Intolerance Treatment Receives FDA Nod
With IND approval, Ritter is permitted to initiate a Phase IIa clinical trial of RP-G28, directly assessing its safety, tolerability and effectiveness in humans. RP-G28’s IND approval confirms
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.